Skip to main content
Atrás
Watch Compare

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Calidad de datos: 100%
CELZ
Nasdaq Manufacturing Chemicals
$2.14
▲ $0.10 (4.90%)
Cap. Mercado: 7.60 M
Precio
$2.06
Cap. Mercado
7.60 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Revenue declined -48.86% annually over 5 years
Negative free cash flow of -5.86 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.41%

Crecimiento

Revenue Growth (5Y)
-48.86%
Below sector avg (1.82%)
Revenue (1Y)-45.45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-96.54%
Below sector avg (-53.41%)
ROIC-78.15%
Net Margin-99916.80%
Op. Margin-102380.23%

Seguridad

Debt / Equity
N/A
Current Ratio20.71
Interest CoverageN/A

Valoración

PE (TTM)
-1.27
Above sector avg (-1.48)
P/B Ratio1.36
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -1.3 -1.5
P/B 1.4 1.6
ROE % -96.5 -53.4
Net Margin % -99916.8 -41.5
Rev Growth 5Y % -48.9 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -45.45% Revenue Growth (3Y) -18.35%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -48.86% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6,000.0 Net Income (TTM) -6.00 M
ROE -96.54% ROA -92.53%
Gross Margin 63.43% Operating Margin -102380.23%
Net Margin -99916.80% Free Cash Flow (TTM) -5.86 M
ROIC -78.15% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 20.71
Interest Coverage N/A Asset Turnover 0.00
Working Capital 5.15 M Tangible Book Value 5.15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.27 Forward P/E N/A
P/B Ratio 1.36 P/S Ratio 1266.36
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -77.08%
Market Cap 7.60 M Enterprise Value 7.60 M
Per Share
EPS (Diluted TTM) -2.52 Revenue / Share 0.00
FCF / Share -1.58 OCF / Share -1.58
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 97.69%
SBC-Adj. FCF -5.87 M Growth Momentum 3.41

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6,000.0 11,000.0 9,000.0 88,600.0 87,754.0
Net Income -6.00 M -5.49 M -5.29 M -10.14 M 19.21 M
EPS (Diluted) -2.52 -3.71 — -0.93 5.61
Gross Profit 3,806.0 6,600.0 5,400.0 60,109.0 39,805.0
Operating Income -6.14 M -5.74 M -5.62 M -10.24 M -3.13 M
EBITDA — — — — —
R&D Expenses 2.26 M 2.40 M 1.97 M 6.27 M 109,180.0
SG&A Expenses 3.76 M 3.24 M 3.56 M 3.94 M 2.96 M
D&A — 56,000.0 56,000.0 — —
Interest Expense — — — 0.0 4.28 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7.81 M 6.67 M 10.72 M 19.19 M 11.27 M
Total Liabilities 284,880.0 327,644.0 371,394.0 3.32 M —
Shareholders' Equity 7.51 M 6.34 M 10.34 M 15.86 M 10.22 M
Total Debt — — — — —
Cash & Equivalents — — — — 10.72 M
Current Assets 7.40 M 6.14 M 10.27 M 18.75 M 10.74 M
Current Liabilities 284,880.0 327,644.0 371,394.0 3.32 M 1.05 M